Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check76 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with the same phrase, suggesting a possible formatting or presentation change rather than a substantive content update.SummaryDifference1.0%
Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.